Search results

Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.

Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.

Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.

With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.

Gain a quick overview of what top trends and topics dominated DIA 2023.

Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.

See why many of the top pharma are focused on building the "next model" of clinical trial conduct using foundational platforms.

Learn how Medable's eCOA (electronic clinical outcome assessment) solution was able to deliver >90% adherence and scalability for a top pharmaceutical weight management clinical trial.

Contact Medable for a demo and to learn more about DCT certification, careers, and support. Medable, per Everest Group Peak matrix, is the top decentralized clinical trial company.

A top 10 pharmaceutical company looked to Medable to streamline participant burden and enhance site and team experience in oncology trials, while establishing a scalable template for future trials in oncology and other areas.

Learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.

Join Medable's Mohammed Ali, Chief Domain Expert and Shubha Govil, SVP of Product Management,Platform to hear how top pharma teams have adopted digital technology across a platform to reduce costs and accelerate time to market.

Medable worked with a top 5 pharma company to increase the safety of patients as anti-cancer treatments may cause pulmonary toxicity, ranging from asymptomatic radiological changes to respiratory failure, and is considered a common side effect.

Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.

See how customers have had success with Medable, our trial platform, and our teams.

In this webinar, learn how top pharma are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.

Learn how we can help you navigate the complexities of clinical operations so that you can meet your study's milestones faster and easier.

The partnership between Medable, U.S. Renal Care, and the top ten pharmaceutical sponsor exemplifies the transformative power of Medable’s Total Consent solution in clinical trials. By overcoming common misconceptions around participant age, cost, and complexity, Medable’s platform proved to be a flexible, fast, and efficient solution for the elderly renal care population. U.S. Renal Care sought to use Medable’s Total Consent (Medable’s eConsent solution) for an investigator-initiated trial. The phase 4 trial, which was funded by a top 10 pharmaceutical company, sought to enroll elderly participants suffering from Anemia ESKD (End Stage Kidney Disease) across 476 site users. The trial would be managed by three central principal investigators (PIs).

See how Medable was able to increase study startup speed for one customer by 50%.

See how Medable helped one customer achieve their fastest enrollment ever.

A top-10 global pharmaceutical company partnered with Medable for their pivotal Phase III diabetes study in the highly competitive market. Recognizing the inefficiencies in traditional study delivery and closeout processes, the company leveraged Medable’s expertise to accelerate timelines, enhance operational efficiency, and achieve a faster time to market for this high-profile therapy.

A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. Recognizing Japan’s distinct regulatory, cultural, and logistical landscape, the company partnered with Medable to develop an initiative to enhance the region’s patient and site experience.

See how a pharmaceutical company used data gathered during the informed consent process to pre-populate their site's systems, as well as their own.

Gain a partner that helps bring speed and savings to your trials with a single platform that scales to support your study and SMEs that are here for your needs from beginning to end.

A top-10 global pharmaceutical company came to Medable looking to standardize and scale their weight management trials. The trial was driven by a master protocol with multiple sub-studies across 70+ research sites. The partner was concerned about the participant and site experience, particularly participant enrollment and study startup timelines, as the trial required participants to enroll through the master protocol before enrolling into a sub-study. Read ahead to see how Medable accomplished this and more.

For the second consecutive year, Medable has been named Leader decentralized clinical trial products per the Everest Group’s PEAK Matrix® assessment, which evaluates DCT products from 24 companies based on vision, capability and market impact.

Joe Dustin, VP/GM of eCOA and Annie Hesslewood, Site & Patient adoption lead at Medable host an open discussion with a panel of sites and CRAs to provide a candid assessment of how upcoming changes in the eCOA landscape can reduce burden on participants and sites to maximize the chance of success in clinical trials.

Camila Matheny, EVP of DCT Offerings at Medable and Caroline Beaufour, PharmD, Ph.D., Innovation Lead, Clinical Development Support at Servier, dive into the intricacies of implementing electronic informed consent (eConsent) in clinical trials within the complex regulatory landscape of European countries.

Learn how clinical trial data collecting is evolving and how Medable is supporting clients with this blog on evidence generation, clinical trial data, DHTs, sensors, wearables, and more.

Consult directly with an award-winning Medable SME about your trial and discover how to enable faster, easier, clinical trials through patient-focused experiences. Chat about best practices in protocol design and digital standardization, learn how the latest FDA & EU guidelines will impact you, or see client use cases on cost and time savings.

Medable’s oncology suite simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.

Discover a unified digital platform for clinical trials with best-in-class decentralized and eCOA software. Streamline data collection, scale globally, and deliver smarter, faster results.

In this webinar, find out how to optimise oncology clinical trials using digital tools to accelerate decision-making.

A summary of JPM2024 news, trends, and highlights that made waves during this year’s conference.

Find events that Medable will be attending this year, along with webinars that we have created or participated in here.

Your questions about decentralized clinical trials answered. Read to learn more about Medable and its cloud based, SaaS tools, from total consent, ecoas, and more